...
首页> 外文期刊>Cellular and Molecular Neurobiology >Recent Development in Studies of Tetrahydroprotoberberines: Mechanism in Antinociception and Drug Addiction
【24h】

Recent Development in Studies of Tetrahydroprotoberberines: Mechanism in Antinociception and Drug Addiction

机译:四氢小ber碱研究的最新进展:抗伤害感受和药物成瘾的机制

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

The tetrahydroprotoberberines (THPBs) are compounds isolated from Chinese herbs that possess a unique pharmacological profile as D2 dopamine receptor antagonists and D1 receptor agonists. l-Tetrahydropalmatine (l-THP) and l-stepholidine (SPD), members of the THPB family, were shown to have potential clinical use in the treatment of pain. However, their mechanism of action is not clear. In the past decades, Chinese scientists have made a great deal of effort to explore the mechanisms by which the THPBs and its analogues elicit antinociception and their potential utility in treating drug abuse. It is now clear that the antinociception produced by l-THP is related to inhibition of D2 dopamine receptors. The present review focuses on the recent progress made in understanding the mechanisms of l-THP- and l-SPD-mediated antinociception and the sequel of drug addiction.
机译:四氢小ber碱(THPBs)是从中草药中分离的化合物,具有独特的药理特性,可作为D2多巴胺受体拮抗剂和D1受体激动剂。 THPB家族成员l-四氢巴马汀(l-THP)和l-stepholidine(SPD)已显示在治疗疼痛方面具有潜在的临床用途。但是,它们的作用机理尚不清楚。在过去的几十年中,中国科学家付出了巨大的努力来探索THPB及其类似物引发抗伤害感受的机制及其在治疗药物滥用中的潜在效用。现已清楚,1-THP产生的抗伤害感受作用与抑制D 2 多巴胺受体有关。本综述着重于在了解l-THP和l-SPD介导的抗伤害感受的机制以及药物成瘾的后遗症方面的最新进展。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号